Treatment of cryptosporidiosis.
Pantenburg
Birte
B
Cabada
Miguel M
MM
White
A Clinton
AC
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000628:therapy; D000818:Animals; D023241:Antiretroviral Therapy, Highly Active; D017963:Azithromycin / Q000627:therapeutic use; D001660:Biliary Tract Diseases / Q000628:therapy; D003049:Coccidiostats / Q000627:therapeutic use; D003457:Cryptosporidiosis / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host; D009574:Nitro Compounds; D010303:Paromomycin / Q000627:therapeutic use; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D013844:Thiazoles / Q000627:therapeutic use
D003049:Coccidiostats; D009574:Nitro Compounds; D012294:Rifamycins; D013844:Thiazoles; D010303:Paromomycin; D017963:Azithromycin; D000078262:Rifaximin; C041747:nitazoxanide